Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00454701 · ClinicalTrials.gov registry record
Assessment and Tracking of Long-term Alefacept Safety
A clinical trial, sponsored by Astellas Pharma.
- Terminated
- Registry status
- 1,897
- Enrollment target
NCT00454701 is a clinical trial that was terminated before completion, run by Astellas Pharma. The registered enrollment target is 1,897 participants.
The verdict
NCT00454701 was terminated before completion, sponsored by Astellas Pharma.
- TERMINATED
- Registry status
- 1,897 participants
- Enrollment target
Study Summary
Subjects exposed to alefacept are to be enrolled. Subjects will be contacted every 6 months to gather general health information.
Interventions
- DRUG Alefacept exposure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,897 participants |
| Start Date | 2003-06 |
| Est. Completion | 2012-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00454701
The ClinicalTrials.gov registry entry for NCT00454701 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1,897 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Astellas Pharma, which has 165 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Alefacept exposure is the first listed.
NCT00454701 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00454701 about?
NCT00454701 is a clinical study titled "Assessment and Tracking of Long-term Alefacept Safety". Subjects exposed to alefacept are to be enrolled. Subjects will be contacted every 6 months to gather general health information.
What is the current status of trial NCT00454701?
This trial is currently terminated. The enrollment target is 1,897 participants. The study started on 2003-06. Estimated completion is 2012-02.
What interventions are being tested in trial NCT00454701?
The interventions under investigation include: Alefacept exposure (DRUG).
Who is sponsoring clinical trial NCT00454701?
This trial is sponsored by Astellas Pharma, which has 165 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.